Jonathan D. Root - 18 Nov 2021 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.

Role: Director, 10%+ Owner
Signature: Dale Holladay, Attorney in Fact for the Reporting Person
Issuer symbol: N/A
Transactions as of: 18 Nov 2021
Net transactions value: -$407,404
Form type: 4
Filing time: 22 Nov 2021, 18:13:22 UTC
Previous filing: 17 Nov 2021
Next filing: 26 Nov 2021
SEC: View on sec.gov

Key filing fact

Jonathan D. Root filed Form 4 for eFFECTOR Therapeutics, Inc. on 22 Nov 2021.

Key facts

This page summarizes Jonathan D. Root's Form 4 filing for eFFECTOR Therapeutics, Inc..
6 reported transactions and 0 derivative rows are listed below.
Filing timestamp: 22 Nov 2021, 18:13.

Change

Previous filing in this sequence was filed on 17 Nov 2021.
Current net transaction value: -$407,404.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

EFTR transaction

Common Stock

Sale

Transaction value: $138,375
Shares: -16,226
Change %: -0.36%
Price: $8.53
Shares after: 4,549,398
Date: 18 Nov 2021
Ownership: Directly owned by USVP X
Footnotes: F1, F2

EFTR transaction

Common Stock

Sale

Transaction value: $4,426
Shares: -519
Change %: -0.36%
Price: $8.53
Shares after: 145,544
Date: 18 Nov 2021
Ownership: Directly owned by AFF X
Footnotes: F1, F2

EFTR transaction

Common Stock

Sale

Transaction value: $56,985
Shares: -7,017
Change %: -0.15%
Price: $8.12
Shares after: 4,542,381
Date: 19 Nov 2021
Ownership: Directly owned by USVP X
Footnotes: F1, F2

EFTR transaction

Common Stock

Sale

Transaction value: $1,819
Shares: -224
Change %: -0.15%
Price: $8.12
Shares after: 145,320
Date: 19 Nov 2021
Ownership: Directly owned by AFF X
Footnotes: F1, F2

EFTR transaction

Common Stock

Sale

Transaction value: $199,416
Shares: -25,371
Change %: -0.56%
Price: $7.86
Shares after: 4,517,010
Date: 22 Nov 2021
Ownership: Directly owned by USVP X
Footnotes: F1, F2

EFTR transaction

Common Stock

Sale

Transaction value: $6,382
Shares: -812
Change %: -0.56%
Price: $7.86
Shares after: 144,508
Date: 22 Nov 2021
Ownership: Directly owned by AFF X
Footnotes: F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.01 to $9.12; inclusive for sales on 11/18/21; prices ranging from $8.04 to $8.24, inclusive for sales on 11/19/21; and prices ranging from $7.75 to $8.06, inclusive for sales on 11/22/21. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4
F2	Presidio Management Group X, L.L.C. ("PMG X"), the general partner of each of U.S. Venture Partners X, L.P. ("USVP X") and USVP X Affiliates L.P. ("AFF X") (together, the "USVP X Funds"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. The Reporting Person is a managing member of PMG X with additional rights with respect to the Issuer securities, and may be deemed to have sole voting and dispositive power with respect to the shares. The Reporting Person disclaims beneficial ownership of shares held by the USVP X Funds, except to the extent of any proportionate pecuniary interest therein.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.01 to $9.12; inclusive for sales on 11/18/21; prices ranging from $8.04 to $8.24, inclusive for sales on 11/19/21; and prices ranging from $7.75 to $8.06, inclusive for sales on 11/22/21. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4

Presidio Management Group X, L.L.C. ("PMG X"), the general partner of each of U.S. Venture Partners X, L.P. ("USVP X") and USVP X Affiliates L.P. ("AFF X") (together, the "USVP X Funds"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. The Reporting Person is a managing member of PMG X with additional rights with respect to the Issuer securities, and may be deemed to have sole voting and dispositive power with respect to the shares. The Reporting Person disclaims beneficial ownership of shares held by the USVP X Funds, except to the extent of any proportionate pecuniary interest therein.